4,7-bis[2-[(2S)-pyrrolidin-2-yl]-3H-benzimidazol-5-yl]spiro[3H-indene-2,1'-cyclopentane]-1-one;tert-butyl (2S)-2-[6-[7-[2-[(2S)-1-[(2-methylpropan-2-yl)oxycarbonyl]pyrrolidin-2-yl]-3H-benzimidazol-5-yl]-1-oxospiro[3H-indene-2,1'-cyclopentane]-4-yl]-1H-benzimidazol-2-yl]pyrrolidine-1-carboxylate;tert-butyl (2S)-2-[6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-benzimidazol-2-yl]pyrrolidine-1-carboxylate;methane;(2S)-2-(methoxycarbonylamino)-3-methylbutanoic acid;methyl N-[(2S)-1-[(2S)-2-[5-[7-[2-[(2S)-1-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]pyrrolidin-2-yl]-3H-benzimidazol-5-yl]-3-oxospiro[1H-indene-2,1'-cyclopentane]-4-yl]-3H-indol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate;(7-methyl-1-oxospiro[3H-indene-2,1'-cyclopentane]-4-yl) trifluoromethanesulfonate

C176H215BF3N23O25S — CID 159193028

IUPAC4,7-bis[2-[(2S)-pyrrolidin-2-yl]-3H-benzimidazol-5-yl]spiro[3H-indene-2,1'-cyclopentane]-1-one;tert-butyl (2S)-2-[6-[7-[2-[(2S)-1-[(2-methylpropan-2-yl)oxycarbonyl]pyrrolidin-2-yl]-3H-benzimidazol-5-yl]-1-oxospiro[3H-indene-2,1'-cyclopentane]-4-yl]-1H-benzimidazol-2-yl]pyrrolidine-1-carboxylate;tert-butyl (2S)-2-[6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-benzimidazol-2-yl]pyrrolidine-1-carboxylate;methane;(2S)-2-(methoxycarbonylamino)-3-methylbutanoic acid;methyl N-[(2S)-1-[(2S)-2-[5-[7-[2-[(2S)-1-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]pyrrolidin-2-yl]-3H-benzimidazol-5-yl]-3-oxospiro[1H-indene-2,1'-cyclopentane]-4-yl]-3H-indol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate;(7-methyl-1-oxospiro[3H-indene-2,1'-cyclopentane]-4-yl) trifluoromethanesulfonate
SMILESC.C.CC(C)(C)OC(=O)N1CCC[C@H]1c1nc2ccc(-c3ccc(-c4ccc5nc([C@@H]6CCCN6C(=O)OC(C)(C)C)[nH]c5c4)c4c3CC3(CCCC3)C4=O)cc2[nH]1.CC(C)(C)OC(=O)N1CCC[C@H]1c1nc2ccc(B3OC(C)(C)C(C)(C)O3)cc2[nH]1.COC(=O)N[C@H](C(=O)N1CCC[C@H]1C1=Nc2ccc(-c3ccc(-c4ccc5nc([C@@H]6CCCN6C(=O)[C@@H](NC(=O)OC)C(C)C)[nH]c5c4)c4c3C(=O)C3(CCCC3)C4)cc2C1)C(C)C.COC(=O)N[C@H](C(=O)O)C(C)C.Cc1ccc(OS(=O)(=O)C(F)(F)F)c2c1C(=O)C1(CCCC1)C2.O=C1c2c(-c3ccc4nc([C@@H]5CCCN5)[nH]c4c3)ccc(-c3ccc4nc([C@@H]5CCCN5)[nH]c4c3)c2CC12CCCC2
InChIInChI=1S/C50H59N7O7.C45H52N6O5.C35H36N6O.C22H32BN3O4.C15H15F3O4S.C7H13NO4.2CH4/c1-27(2)42(54-48(61)63-5)46(59)56-21-9-11-39(56)38-25-31-23-29(13-17-35(31)51-38)33-16-15-32(34-26-50(19-7-8-20-50)44(58)41(33)34)30-14-18-36-37(24-30)53-45(52-36)40-12-10-22-57(40)47(60)43(28(3)4)55-49(62)64-6;1-43(2,3)55-41(53)50-21-9-11-35(50)39-46-31-17-13-26(23-33(31)48-39)28-15-16-29(37-30(28)25-45(38(37)52)19-7-8-20-45)27-14-18-32-34(24-27)49-40(47-32)36-12-10-22-51(36)42(54)56-44(4,5)6;42-32-31-23(21-8-12-26-30(18-21)41-34(39-26)28-6-4-16-37-28)10-9-22(24(31)19-35(32)13-1-2-14-35)20-7-11-25-29(17-20)40-33(38-25)27-5-3-15-36-27;1-20(2,3)28-19(27)26-12-8-9-17(26)18-24-15-11-10-14(13-16(15)25-18)23-29-21(4,5)22(6,7)30-23;1-9-4-5-11(22-23(20,21)15(16,17)18)10-8-14(6-2-3-7-14)13(19)12(9)10;1-4(2)5(6(9)10)8-7(11)12-3;;/h13-18,23-24,27-28,39-40,42-43H,7-12,19-22,25-26H2,1-6H3,(H,52,53)(H,54,61)(H,55,62);13-18,23-24,35-36H,7-12,19-22,25H2,1-6H3,(H,46,48)(H,47,49);7-12,17-18,27-28,36-37H,1-6,13-16,19H2,(H,38,40)(H,39,41);10-11,13,17H,8-9,12H2,1-7H3,(H,24,25);4-5H,2-3,6-8H2,1H3;4-5H,1-3H3,(H,8,11)(H,9,10);2*1H4/t39-,40-,42-,43-;35-,36-;27-,28-;17-;;5-;;/m0000.0../s1
InChIKeyKOIDFKWHLUEQEG-LFRBCECCSA-N
MW3152.66 g/mol
LogP34.56
Rot. Bonds25

About 4,7-bis[2-[(2S)-pyrrolidin-2-yl]-3H-benzimidazol-5-yl]spiro[3H-indene-2,1'-cyclopentane]-1-one;tert-butyl (2S)-2-[6-[7-[2-[(2S)-1-[(2-methylpropan-2-yl)oxycarbonyl]pyrrolidin-2-yl]-3H-benzimidazol-5-yl]-1-oxospiro[3H-indene-2,1'-cyclopentane]-4-yl]-1H-benzimidazol-2-yl]pyrrolidine-1-carboxylate;tert-butyl (2S)-2-[6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-benzimidazol-2-yl]pyrrolidine-1-carboxylate;methane;(2S)-2-(methoxycarbonylamino)-3-methylbutanoic acid;methyl N-[(2S)-1-[(2S)-2-[5-[7-[2-[(2S)-1-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]pyrrolidin-2-yl]-3H-benzimidazol-5-yl]-3-oxospiro[1H-indene-2,1'-cyclopentane]-4-yl]-3H-indol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate;(7-methyl-1-oxospiro[3H-indene-2,1'-cyclopentane]-4-yl) trifluoromethanesulfonate

4,7-bis[2-[(2S)-pyrrolidin-2-yl]-3H-benzimidazol-5-yl]spiro[3H-indene-2,1'-cyclopentane]-1-one;tert-butyl (2S)-2-[6-[7-[2-[(2S)-1-[(2-methylpropan-2-yl)oxycarbonyl]pyrrolidin-2-yl]-3H-benzimidazol-5-yl]-1-oxospiro[3H-indene-2,1'-cyclopentane]-4-yl]-1H-benzimidazol-2-yl]pyrrolidine-1-carboxylate;tert-butyl (2S)-2-[6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-benzimidazol-2-yl]pyrrolidine-1-carboxylate;methane;(2S)-2-(methoxycarbonylamino)-3-methylbutanoic acid;methyl N-[(2S)-1-[(2S)-2-[5-[7-[2-[(2S)-1-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]pyrrolidin-2-yl]-3H-benzimidazol-5-yl]-3-oxospiro[1H-indene-2,1'-cyclopentane]-4-yl]-3H-indol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate;(7-methyl-1-oxospiro[3H-indene-2,1'-cyclopentane]-4-yl) trifluoromethanesulfonate (PubChem CID 159193028) has the molecular formula C176H215BF3N23O25S and a molecular weight of 3152.66 g/mol. Its IUPAC name is 4,7-bis[2-[(2S)-pyrrolidin-2-yl]-3H-benzimidazol-5-yl]spiro[3H-indene-2,1'-cyclopentane]-1-one;tert-butyl (2S)-2-[6-[7-[2-[(2S)-1-[(2-methylpropan-2-yl)oxycarbonyl]pyrrolidin-2-yl]-3H-benzimidazol-5-yl]-1-oxospiro[3H-indene-2,1'-cyclopentane]-4-yl]-1H-benzimidazol-2-yl]pyrrolidine-1-carboxylate;tert-butyl (2S)-2-[6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-benzimidazol-2-yl]pyrrolidine-1-carboxylate;methane;(2S)-2-(methoxycarbonylamino)-3-methylbutanoic acid;methyl N-[(2S)-1-[(2S)-2-[5-[7-[2-[(2S)-1-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]pyrrolidin-2-yl]-3H-benzimidazol-5-yl]-3-oxospiro[1H-indene-2,1'-cyclopentane]-4-yl]-3H-indol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate;(7-methyl-1-oxospiro[3H-indene-2,1'-cyclopentane]-4-yl) trifluoromethanesulfonate.

Molecular Properties

Compound Name4,7-bis[2-[(2S)-pyrrolidin-2-yl]-3H-benzimidazol-5-yl]spiro[3H-indene-2,1'-cyclopentane]-1-one;tert-butyl (2S)-2-[6-[7-[2-[(2S)-1-[(2-methylpropan-2-yl)oxycarbonyl]pyrrolidin-2-yl]-3H-benzimidazol-5-yl]-1-oxospiro[3H-indene-2,1'-cyclopentane]-4-yl]-1H-benzimidazol-2-yl]pyrrolidine-1-carboxylate;tert-butyl (2S)-2-[6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-benzimidazol-2-yl]pyrrolidine-1-carboxylate;methane;(2S)-2-(methoxycarbonylamino)-3-methylbutanoic acid;methyl N-[(2S)-1-[(2S)-2-[5-[7-[2-[(2S)-1-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]pyrrolidin-2-yl]-3H-benzimidazol-5-yl]-3-oxospiro[1H-indene-2,1'-cyclopentane]-4-yl]-3H-indol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate;(7-methyl-1-oxospiro[3H-indene-2,1'-cyclopentane]-4-yl) trifluoromethanesulfonate
PubChem CID159193028
Molecular FormulaC176H215BF3N23O25S
Molecular Weight3152.66 g/mol
Exact Mass3150.60
IUPAC Name4,7-bis[2-[(2S)-pyrrolidin-2-yl]-3H-benzimidazol-5-yl]spiro[3H-indene-2,1'-cyclopentane]-1-one;tert-butyl (2S)-2-[6-[7-[2-[(2S)-1-[(2-methylpropan-2-yl)oxycarbonyl]pyrrolidin-2-yl]-3H-benzimidazol-5-yl]-1-oxospiro[3H-indene-2,1'-cyclopentane]-4-yl]-1H-benzimidazol-2-yl]pyrrolidine-1-carboxylate;tert-butyl (2S)-2-[6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-benzimidazol-2-yl]pyrrolidine-1-carboxylate;methane;(2S)-2-(methoxycarbonylamino)-3-methylbutanoic acid;methyl N-[(2S)-1-[(2S)-2-[5-[7-[2-[(2S)-1-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]pyrrolidin-2-yl]-3H-benzimidazol-5-yl]-3-oxospiro[1H-indene-2,1'-cyclopentane]-4-yl]-3H-indol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate;(7-methyl-1-oxospiro[3H-indene-2,1'-cyclopentane]-4-yl) trifluoromethanesulfonate
SMILESC.C.CC(C)(C)OC(=O)N1CCC[C@H]1c1nc2ccc(-c3ccc(-c4ccc5nc([C@@H]6CCCN6C(=O)OC(C)(C)C)[nH]c5c4)c4c3CC3(CCCC3)C4=O)cc2[nH]1.CC(C)(C)OC(=O)N1CCC[C@H]1c1nc2ccc(B3OC(C)(C)C(C)(C)O3)cc2[nH]1.COC(=O)N[C@H](C(=O)N1CCC[C@H]1C1=Nc2ccc(-c3ccc(-c4ccc5nc([C@@H]6CCCN6C(=O)[C@@H](NC(=O)OC)C(C)C)[nH]c5c4)c4c3C(=O)C3(CCCC3)C4)cc2C1)C(C)C.COC(=O)N[C@H](C(=O)O)C(C)C.Cc1ccc(OS(=O)(=O)C(F)(F)F)c2c1C(=O)C1(CCCC1)C2.O=C1c2c(-c3ccc4nc([C@@H]5CCCN5)[nH]c4c3)ccc(-c3ccc4nc([C@@H]5CCCN5)[nH]c4c3)c2CC12CCCC2
InChIInChI=1S/C50H59N7O7.C45H52N6O5.C35H36N6O.C22H32BN3O4.C15H15F3O4S.C7H13NO4.2CH4/c1-27(2)42(54-48(61)63-5)46(59)56-21-9-11-39(56)38-25-31-23-29(13-17-35(31)51-38)33-16-15-32(34-26-50(19-7-8-20-50)44(58)41(33)34)30-14-18-36-37(24-30)53-45(52-36)40-12-10-22-57(40)47(60)43(28(3)4)55-49(62)64-6;1-43(2,3)55-41(53)50-21-9-11-35(50)39-46-31-17-13-26(23-33(31)48-39)28-15-16-29(37-30(28)25-45(38(37)52)19-7-8-20-45)27-14-18-32-34(24-27)49-40(47-32)36-12-10-22-51(36)42(54)56-44(4,5)6;42-32-31-23(21-8-12-26-30(18-21)41-34(39-26)28-6-4-16-37-28)10-9-22(24(31)19-35(32)13-1-2-14-35)20-7-11-25-29(17-20)40-33(38-25)27-5-3-15-36-27;1-20(2,3)28-19(27)26-12-8-9-17(26)18-24-15-11-10-14(13-16(15)25-18)23-29-21(4,5)22(6,7)30-23;1-9-4-5-11(22-23(20,21)15(16,17)18)10-8-14(6-2-3-7-14)13(19)12(9)10;1-4(2)5(6(9)10)8-7(11)12-3;;/h13-18,23-24,27-28,39-40,42-43H,7-12,19-22,25-26H2,1-6H3,(H,52,53)(H,54,61)(H,55,62);13-18,23-24,35-36H,7-12,19-22,25H2,1-6H3,(H,46,48)(H,47,49);7-12,17-18,27-28,36-37H,1-6,13-16,19H2,(H,38,40)(H,39,41);10-11,13,17H,8-9,12H2,1-7H3,(H,24,25);4-5H,2-3,6-8H2,1H3;4-5H,1-3H3,(H,8,11)(H,9,10);2*1H4/t39-,40-,42-,43-;35-,36-;27-,28-;17-;;5-;;/m0000.0../s1
InChIKeyKOIDFKWHLUEQEG-LFRBCECCSA-N
XLogP34.56
TPSA620.14 Ų
H-Bond Donors12
H-Bond Acceptors33
Rotatable Bonds25
Heavy Atoms229
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5003152.66
LogP ≤ 534.56
H-Bond Donors ≤ 512
H-Bond Acceptors ≤ 1033

Computed Properties (RDKit)

Structural Alerts{'alert_name': '>_2_ester_groups', 'substructure': 'N/A'}, {'alert_name': 'heavy_metal', 'substructure': 'N/A'}, {'alert_name': 'Sulfonic_acid_1', 'substructure': 'N/A'}, {'alert_name': 'triflate', 'substructure': 'N/A'}

Analyze 4,7-bis[2-[(2S)-pyrrolidin-2-yl]-3H-benzimidazol-5-yl]spiro[3H-indene-2,1'-cyclopentane]-1-one;tert-butyl (2S)-2-[6-[7-[2-[(2S)-1-[(2-methylpropan-2-yl)oxycarbonyl]pyrrolidin-2-yl]-3H-benzimidazol-5-yl]-1-oxospiro[3H-indene-2,1'-cyclopentane]-4-yl]-1H-benzimidazol-2-yl]pyrrolidine-1-carboxylate;tert-butyl (2S)-2-[6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-benzimidazol-2-yl]pyrrolidine-1-carboxylate;methane;(2S)-2-(methoxycarbonylamino)-3-methylbutanoic acid;methyl N-[(2S)-1-[(2S)-2-[5-[7-[2-[(2S)-1-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]pyrrolidin-2-yl]-3H-benzimidazol-5-yl]-3-oxospiro[1H-indene-2,1'-cyclopentane]-4-yl]-3H-indol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate;(7-methyl-1-oxospiro[3H-indene-2,1'-cyclopentane]-4-yl) trifluoromethanesulfonate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 4,7-bis[2-[(2S)-pyrrolidin-2-yl]-3H-benzimidazol-5-yl]spiro[3H-indene-2,1'-cyclopentane]-1-one;tert-butyl (2S)-2-[6-[7-[2-[(2S)-1-[(2-methylpropan-2-yl)oxycarbonyl]pyrrolidin-2-yl]-3H-benzimidazol-5-yl]-1-oxospiro[3H-indene-2,1'-cyclopentane]-4-yl]-1H-benzimidazol-2-yl]pyrrolidine-1-carboxylate;tert-butyl (2S)-2-[6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-benzimidazol-2-yl]pyrrolidine-1-carboxylate;methane;(2S)-2-(methoxycarbonylamino)-3-methylbutanoic acid;methyl N-[(2S)-1-[(2S)-2-[5-[7-[2-[(2S)-1-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]pyrrolidin-2-yl]-3H-benzimidazol-5-yl]-3-oxospiro[1H-indene-2,1'-cyclopentane]-4-yl]-3H-indol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate;(7-methyl-1-oxospiro[3H-indene-2,1'-cyclopentane]-4-yl) trifluoromethanesulfonate?
The IUPAC name of 4,7-bis[2-[(2S)-pyrrolidin-2-yl]-3H-benzimidazol-5-yl]spiro[3H-indene-2,1'-cyclopentane]-1-one;tert-butyl (2S)-2-[6-[7-[2-[(2S)-1-[(2-methylpropan-2-yl)oxycarbonyl]pyrrolidin-2-yl]-3H-benzimidazol-5-yl]-1-oxospiro[3H-indene-2,1'-cyclopentane]-4-yl]-1H-benzimidazol-2-yl]pyrrolidine-1-carboxylate;tert-butyl (2S)-2-[6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-benzimidazol-2-yl]pyrrolidine-1-carboxylate;methane;(2S)-2-(methoxycarbonylamino)-3-methylbutanoic acid;methyl N-[(2S)-1-[(2S)-2-[5-[7-[2-[(2S)-1-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]pyrrolidin-2-yl]-3H-benzimidazol-5-yl]-3-oxospiro[1H-indene-2,1'-cyclopentane]-4-yl]-3H-indol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate;(7-methyl-1-oxospiro[3H-indene-2,1'-cyclopentane]-4-yl) trifluoromethanesulfonate (CID 159193028) is 4,7-bis[2-[(2S)-pyrrolidin-2-yl]-3H-benzimidazol-5-yl]spiro[3H-indene-2,1'-cyclopentane]-1-one;tert-butyl (2S)-2-[6-[7-[2-[(2S)-1-[(2-methylpropan-2-yl)oxycarbonyl]pyrrolidin-2-yl]-3H-benzimidazol-5-yl]-1-oxospiro[3H-indene-2,1'-cyclopentane]-4-yl]-1H-benzimidazol-2-yl]pyrrolidine-1-carboxylate;tert-butyl (2S)-2-[6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-benzimidazol-2-yl]pyrrolidine-1-carboxylate;methane;(2S)-2-(methoxycarbonylamino)-3-methylbutanoic acid;methyl N-[(2S)-1-[(2S)-2-[5-[7-[2-[(2S)-1-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]pyrrolidin-2-yl]-3H-benzimidazol-5-yl]-3-oxospiro[1H-indene-2,1'-cyclopentane]-4-yl]-3H-indol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate;(7-methyl-1-oxospiro[3H-indene-2,1'-cyclopentane]-4-yl) trifluoromethanesulfonate.
What is the SMILES notation for 4,7-bis[2-[(2S)-pyrrolidin-2-yl]-3H-benzimidazol-5-yl]spiro[3H-indene-2,1'-cyclopentane]-1-one;tert-butyl (2S)-2-[6-[7-[2-[(2S)-1-[(2-methylpropan-2-yl)oxycarbonyl]pyrrolidin-2-yl]-3H-benzimidazol-5-yl]-1-oxospiro[3H-indene-2,1'-cyclopentane]-4-yl]-1H-benzimidazol-2-yl]pyrrolidine-1-carboxylate;tert-butyl (2S)-2-[6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-benzimidazol-2-yl]pyrrolidine-1-carboxylate;methane;(2S)-2-(methoxycarbonylamino)-3-methylbutanoic acid;methyl N-[(2S)-1-[(2S)-2-[5-[7-[2-[(2S)-1-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]pyrrolidin-2-yl]-3H-benzimidazol-5-yl]-3-oxospiro[1H-indene-2,1'-cyclopentane]-4-yl]-3H-indol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate;(7-methyl-1-oxospiro[3H-indene-2,1'-cyclopentane]-4-yl) trifluoromethanesulfonate?
The canonical SMILES for 4,7-bis[2-[(2S)-pyrrolidin-2-yl]-3H-benzimidazol-5-yl]spiro[3H-indene-2,1'-cyclopentane]-1-one;tert-butyl (2S)-2-[6-[7-[2-[(2S)-1-[(2-methylpropan-2-yl)oxycarbonyl]pyrrolidin-2-yl]-3H-benzimidazol-5-yl]-1-oxospiro[3H-indene-2,1'-cyclopentane]-4-yl]-1H-benzimidazol-2-yl]pyrrolidine-1-carboxylate;tert-butyl (2S)-2-[6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-benzimidazol-2-yl]pyrrolidine-1-carboxylate;methane;(2S)-2-(methoxycarbonylamino)-3-methylbutanoic acid;methyl N-[(2S)-1-[(2S)-2-[5-[7-[2-[(2S)-1-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]pyrrolidin-2-yl]-3H-benzimidazol-5-yl]-3-oxospiro[1H-indene-2,1'-cyclopentane]-4-yl]-3H-indol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate;(7-methyl-1-oxospiro[3H-indene-2,1'-cyclopentane]-4-yl) trifluoromethanesulfonate is C.C.CC(C)(C)OC(=O)N1CCC[C@H]1c1nc2ccc(-c3ccc(-c4ccc5nc([C@@H]6CCCN6C(=O)OC(C)(C)C)[nH]c5c4)c4c3CC3(CCCC3)C4=O)cc2[nH]1.CC(C)(C)OC(=O)N1CCC[C@H]1c1nc2ccc(B3OC(C)(C)C(C)(C)O3)cc2[nH]1.COC(=O)N[C@H](C(=O)N1CCC[C@H]1C1=Nc2ccc(-c3ccc(-c4ccc5nc([C@@H]6CCCN6C(=O)[C@@H](NC(=O)OC)C(C)C)[nH]c5c4)c4c3C(=O)C3(CCCC3)C4)cc2C1)C(C)C.COC(=O)N[C@H](C(=O)O)C(C)C.Cc1ccc(OS(=O)(=O)C(F)(F)F)c2c1C(=O)C1(CCCC1)C2.O=C1c2c(-c3ccc4nc([C@@H]5CCCN5)[nH]c4c3)ccc(-c3ccc4nc([C@@H]5CCCN5)[nH]c4c3)c2CC12CCCC2.
What is the InChIKey of 4,7-bis[2-[(2S)-pyrrolidin-2-yl]-3H-benzimidazol-5-yl]spiro[3H-indene-2,1'-cyclopentane]-1-one;tert-butyl (2S)-2-[6-[7-[2-[(2S)-1-[(2-methylpropan-2-yl)oxycarbonyl]pyrrolidin-2-yl]-3H-benzimidazol-5-yl]-1-oxospiro[3H-indene-2,1'-cyclopentane]-4-yl]-1H-benzimidazol-2-yl]pyrrolidine-1-carboxylate;tert-butyl (2S)-2-[6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-benzimidazol-2-yl]pyrrolidine-1-carboxylate;methane;(2S)-2-(methoxycarbonylamino)-3-methylbutanoic acid;methyl N-[(2S)-1-[(2S)-2-[5-[7-[2-[(2S)-1-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]pyrrolidin-2-yl]-3H-benzimidazol-5-yl]-3-oxospiro[1H-indene-2,1'-cyclopentane]-4-yl]-3H-indol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate;(7-methyl-1-oxospiro[3H-indene-2,1'-cyclopentane]-4-yl) trifluoromethanesulfonate?
The InChIKey is KOIDFKWHLUEQEG-LFRBCECCSA-N. The full InChI is InChI=1S/C50H59N7O7.C45H52N6O5.C35H36N6O.C22H32BN3O4.C15H15F3O4S.C7H13NO4.2CH4/c1-27(2)42(54-48(61)63-5)46(59)56-21-9-11-39(56)38-25-31-23-29(13-17-35(31)51-38)33-16-15-32(34-26-50(19-7-8-20-50)44(58)41(33)34)30-14-18-36-37(24-30)53-45(52-36)40-12-10-22-57(40)47(60)43(28(3)4)55-49(62)64-6;1-43(2,3)55-41(53)50-21-9-11-35(50)39-46-31-17-13-26(23-33(31)48-39)28-15-16-29(37-30(28)25-45(38(37)52)19-7-8-20-45)27-14-18-32-34(24-27)49-40(47-32)36-12-10-22-51(36)42(54)56-44(4,5)6;42-32-31-23(21-8-12-26-30(18-21)41-34(39-26)28-6-4-16-37-28)10-9-22(24(31)19-35(32)13-1-2-14-35)20-7-11-25-29(17-20)40-33(38-25)27-5-3-15-36-27;1-20(2,3)28-19(27)26-12-8-9-17(26)18-24-15-11-10-14(13-16(15)25-18)23-29-21(4,5)22(6,7)30-23;1-9-4-5-11(22-23(20,21)15(16,17)18)10-8-14(6-2-3-7-14)13(19)12(9)10;1-4(2)5(6(9)10)8-7(11)12-3;;/h13-18,23-24,27-28,39-40,42-43H,7-12,19-22,25-26H2,1-6H3,(H,52,53)(H,54,61)(H,55,62);13-18,23-24,35-36H,7-12,19-22,25H2,1-6H3,(H,46,48)(H,47,49);7-12,17-18,27-28,36-37H,1-6,13-16,19H2,(H,38,40)(H,39,41);10-11,13,17H,8-9,12H2,1-7H3,(H,24,25);4-5H,2-3,6-8H2,1H3;4-5H,1-3H3,(H,8,11)(H,9,10);2*1H4/t39-,40-,42-,43-;35-,36-;27-,28-;17-;;5-;;/m0000.0../s1.
What are the key properties of 4,7-bis[2-[(2S)-pyrrolidin-2-yl]-3H-benzimidazol-5-yl]spiro[3H-indene-2,1'-cyclopentane]-1-one;tert-butyl (2S)-2-[6-[7-[2-[(2S)-1-[(2-methylpropan-2-yl)oxycarbonyl]pyrrolidin-2-yl]-3H-benzimidazol-5-yl]-1-oxospiro[3H-indene-2,1'-cyclopentane]-4-yl]-1H-benzimidazol-2-yl]pyrrolidine-1-carboxylate;tert-butyl (2S)-2-[6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-benzimidazol-2-yl]pyrrolidine-1-carboxylate;methane;(2S)-2-(methoxycarbonylamino)-3-methylbutanoic acid;methyl N-[(2S)-1-[(2S)-2-[5-[7-[2-[(2S)-1-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]pyrrolidin-2-yl]-3H-benzimidazol-5-yl]-3-oxospiro[1H-indene-2,1'-cyclopentane]-4-yl]-3H-indol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate;(7-methyl-1-oxospiro[3H-indene-2,1'-cyclopentane]-4-yl) trifluoromethanesulfonate?
4,7-bis[2-[(2S)-pyrrolidin-2-yl]-3H-benzimidazol-5-yl]spiro[3H-indene-2,1'-cyclopentane]-1-one;tert-butyl (2S)-2-[6-[7-[2-[(2S)-1-[(2-methylpropan-2-yl)oxycarbonyl]pyrrolidin-2-yl]-3H-benzimidazol-5-yl]-1-oxospiro[3H-indene-2,1'-cyclopentane]-4-yl]-1H-benzimidazol-2-yl]pyrrolidine-1-carboxylate;tert-butyl (2S)-2-[6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-benzimidazol-2-yl]pyrrolidine-1-carboxylate;methane;(2S)-2-(methoxycarbonylamino)-3-methylbutanoic acid;methyl N-[(2S)-1-[(2S)-2-[5-[7-[2-[(2S)-1-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]pyrrolidin-2-yl]-3H-benzimidazol-5-yl]-3-oxospiro[1H-indene-2,1'-cyclopentane]-4-yl]-3H-indol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate;(7-methyl-1-oxospiro[3H-indene-2,1'-cyclopentane]-4-yl) trifluoromethanesulfonate has a molecular weight of 3152.66 g/mol, XLogP of 34.56, 25 rotatable bonds, 12 hydrogen bond donors, and 33 hydrogen bond acceptors.
Where does this data come from?
All data for 4,7-bis[2-[(2S)-pyrrolidin-2-yl]-3H-benzimidazol-5-yl]spiro[3H-indene-2,1'-cyclopentane]-1-one;tert-butyl (2S)-2-[6-[7-[2-[(2S)-1-[(2-methylpropan-2-yl)oxycarbonyl]pyrrolidin-2-yl]-3H-benzimidazol-5-yl]-1-oxospiro[3H-indene-2,1'-cyclopentane]-4-yl]-1H-benzimidazol-2-yl]pyrrolidine-1-carboxylate;tert-butyl (2S)-2-[6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-benzimidazol-2-yl]pyrrolidine-1-carboxylate;methane;(2S)-2-(methoxycarbonylamino)-3-methylbutanoic acid;methyl N-[(2S)-1-[(2S)-2-[5-[7-[2-[(2S)-1-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]pyrrolidin-2-yl]-3H-benzimidazol-5-yl]-3-oxospiro[1H-indene-2,1'-cyclopentane]-4-yl]-3H-indol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate;(7-methyl-1-oxospiro[3H-indene-2,1'-cyclopentane]-4-yl) trifluoromethanesulfonate is sourced from PubChem (CID 159193028), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).